Modifying the Poor Prognosis Associated with 18F-FDG-Avid NET with Peptide Receptor Chemo-Radionuclide Therapy (PRCRT)
- PMID: 25814516
- DOI: 10.2967/jnumed.115.154500
Modifying the Poor Prognosis Associated with 18F-FDG-Avid NET with Peptide Receptor Chemo-Radionuclide Therapy (PRCRT)
Comment in
-
Reply: Modifying the Poor Prognosis Associated with 18F-FDG-Avid NET with Peptide Receptor Chemo-Radionuclide Therapy (PRCRT).J Nucl Med. 2015 Jun;56(6):969. doi: 10.2967/jnumed.115.158006. Epub 2015 Apr 23. J Nucl Med. 2015. PMID: 25908828 No abstract available.
Comment on
-
High prognostic value of 18F-FDG PET for metastatic gastroenteropancreatic neuroendocrine tumors: a long-term evaluation.J Nucl Med. 2014 Nov;55(11):1786-90. doi: 10.2967/jnumed.114.144386. Epub 2014 Oct 6. J Nucl Med. 2014. PMID: 25286923
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical